<?xml version="1.0" encoding="UTF-8"?>
<p id="para130">The children were concomitantly vaccinated under the Expanded Programme on Immunization schedule against yellow fever and measles at 8–12 months of age. Ghanaian children received the YF-17DD yellow fever vaccine strain (Bio-Manguinhos-Fiocruz, Rio de Janeiro, Brazil), and Malian children were vaccinated with the YF-17D-213 strain (Chumakov Institute of Poliomyelitis and Viral Encephalitides of the Russian Academy of Sciences, Moscow, Russia). The children provided serum samples either around 2·3 and 6·0 years (PsATT-004 and Pers-004, Ghana) or 4·5 years (Pers-007, Mali) after vaccination (
 <xref rid="tbl1" ref-type="table">table 1</xref>). Only healthy children with available day-0 sera, a complete follow-up history, and no record of yellow fever revaccination were included; children who were seropositive for yellow fever at baseline were excluded.
</p>
